Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
Recruiting · NCT05620771 · Registry updated 2026-05-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2026-05-26 | NCT05620771 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| Northwestern University | 381 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northwestern Medicine Delnor Hospital | Geneva | United States | 2 |
| Northwestern Medicine Grayslake Outpatient Center | Grayslake | United States | 74 |
| Northwestern Medicine Kishwaukee Hospital | DeKalb | United States | 2 |
| Northwestern Medicine Lake Forest Hospital | Lake Forest | United States | 150 |
| Northwestern Medicine Orland Park | Orland Park | United States | 91 |
| Northwestern Medicine Warrenville | Warrenville | United States | 3 |
| Northwestern University | Chicago | United States | 727 |